about
Biological treatments in Behçet's disease: beyond anti-TNF therapy.Update on the Medical Management of Gastrointestinal Behçet's Disease.The Effect of Bisphenol A on Puberty: A Critical Review of the Medical Literature.Defective activation of the MAPK/ERK pathway, leading to PARP1 and DNMT1 dysregulation, is a common defect in IgA nephropathy and Henoch-Schönlein purpura.Unveiling the Efficacy, Safety, and Tolerability of Anti-Interleukin-1 Treatment in Monogenic and Multifactorial Autoinflammatory DiseasesResolution of femoral metaphyseal dysplasia in CINCA syndrome after long-term treatment with interleukin-1 blockadeHints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory DiseasesA possible still role for colchicine in children with idiopathic recurrent acute pericarditis?Long-Term Effectiveness of Secukinumab in Patients with Axial SpondyloarthritisNew Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy
P50
Q33908217-D6199DFA-C11F-42CE-B9DB-211638B21229Q37624811-CFD2D07F-55D3-400B-A4CE-4BB42C551ACDQ41659656-C429A7AF-8DCA-4544-97B6-E8241A26D0F8Q52677761-938B5C2D-2E22-46CC-8D6B-1A35175784AAQ64249669-1CF8C760-A09C-4AC9-B28F-6645C0C9EF26Q88687874-FBF00ADB-D4DB-4B71-80FE-F27B96D20060Q89819649-0C0DF6A5-95B0-4BCF-98DE-F04A1F57A10CQ90295262-3F59DB31-48B2-4DA0-BC37-A15994E663A3Q92131559-6D0767E1-B12F-4821-89EC-1B09CFFFBC5CQ94919856-961ACACB-0753-43DA-AF6B-62FABBCC1C7A
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Donato Rigante
@en
Donato Rigante
@nl
type
label
Donato Rigante
@en
Donato Rigante
@nl
prefLabel
Donato Rigante
@en
Donato Rigante
@nl
P31
P496
0000-0001-7032-7779